Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter to the Editor
  • Published:

Angiogenic balance and diagnosis of pre-eclampsia: selecting the right VEGF receptor

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Rath G, Tripathi R . VEGF and its soluble receptor VEGFR-2 in hypertensive disorders during pregnancy: the Indian scenario. J Hum Hypertens 2012; 26(3): 196–204.

    Article  CAS  Google Scholar 

  2. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003; 111: 649–658.

    Article  CAS  Google Scholar 

  3. Tsatsaris V, Goffin F, Munaut C, Brichant JF, Pignon MR, Noel A et al. Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences. J Clin Endocrinol Metab 2003; 88: 5555–5563.

    Article  CAS  Google Scholar 

  4. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004; 350: 672–683.

    Article  CAS  Google Scholar 

  5. Lim JH, Kim SY, Park SY, Yang JH, Kim MY, Ryu HM . Effective prediction of preeclampsia by a combined ratio of angiogenesis-related factors. Obstet Gynecol 2008; 111: 1403–1409.

    Article  CAS  Google Scholar 

  6. Verlohren S, Galindo A, Schlembach D, Zeisler H, Herraiz I, Moertl MG et al. An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsia. Am J Obstet Gynecol 2010; 202: 161 e161–161 e111.

    Article  Google Scholar 

  7. Polliotti BM, Fry AG, Saller DN, Mooney RA, Cox C, Miller RK . Second-trimester maternal serum placental growth factor and vascular endothelial growth factor for predicting severe, early-onset preeclampsia. Obstet Gynecol 2003; 101: 1266–1274.

    CAS  PubMed  Google Scholar 

  8. De Vivo A, Baviera G, Giordano D, Todarello G, Corrado F, D’anna R . Endoglin, PlGF and sFlt-1 as markers for predicting pre-eclampsia. Acta Obstet Gynecol Scand 2008; 87: 837–842.

    Article  CAS  Google Scholar 

  9. Aggarwal PK, Chandel N, Jain V, Jha V . The relationship between circulating endothelin-1, soluble fms-like tyrosine kinase-1 and soluble endoglin in preeclampsia. J Hum Hypertens 2011 (e-pub ahead of print 31 March 2011; doi: 10.1038/jhh.2011.29).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to V Jha.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jha, V., Aggarwal, P., Chandel, N. et al. Angiogenic balance and diagnosis of pre-eclampsia: selecting the right VEGF receptor. J Hum Hypertens 26, 205–206 (2012). https://doi.org/10.1038/jhh.2011.89

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jhh.2011.89

This article is cited by

Search

Quick links